Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study

1. Laubach, J.P.
2. Schjesvold, F.
3. Mariz, M.
4. Dimopoulos, M.A.
5. Lech-Maranda, E.
6. Spicka, I.
7. Hungria, V.T.M.
8. Shelekhova, T.
9. Abdo, A.
10. Jacobasch, L.
11. Polprasert, C.
12. Hájek, R.
13. Illés, Á.
14. Wróbel, T.
15. Sureda, A.
16. Beksac, M.
17. Gonçalves, I.Z.
18. Bladé, J.
19. Rajkumar, S.V.
20. Chari, A.
21. Lonial, S.
22. Spencer, A.
23. Maison-Blanche, P.
24. Moreau, P.
25. San-Miguel, J.F.
26. Richardson, P.G.
27. Mostrar todos os autores +